-
Chromogenic In Situ Hybridization (CISH) (Technique) Market Share Breakdown of Key Players: 2019 & 2025
Nowak, PhD, the company has evolved from a Roswell Park Comprehensive Cancer Center spin-out in 2006 to a provider of Fluorescence In Situ Hybridization and
Chromogenic In Situ Hybridization probes.
Several techniques like immunohistochemistry (IHC) on paraffin-embedded tissues for HER-2/neu protein detection, Southern blot analysis, a reverse transcription-polymerase chain reaction (RT-PCR) technique
chromogenic in situ hybridization (CISH) technique and fluorescence in situ hybridization (FISH) to quantify HER2/neu are now available.
Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour
chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization.
The HER2 and chromosome 17 probes are detected by using two-color
chromogenic in situ hybridization (ISH) in formalin-fixed, paraffin-embedded breast cancer tissue.
Evaluation of sexing in boar sperm using
chromogenic in situ hybridization. J.
The SPOT-Light test, manufactured by Invitrogen Corp., uses
chromogenic in situ hybridization (CISH) technology to amplify the HER2 gene in breast tissue.
Chromogenic in situ hybridization (CISH) has received increased attention as an alternative technique to FISH and other cytogenetic methods for the detection of chromosomal alterations in breast cancer.
Since the dual ISH assay uses 2-color
chromogenic in situ hybridization to determine gene status, these slides, unlike the FISH slides, can be archived and do not fade over time.
(80.) Mayr D, Heim S, Weyrauch K, et al:
Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: Comparison of a new dual-colour
chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization.